GOAL 3
PrivateLast Round
Grant
Mar 9, 2026
Total Funding Raised
$2.27M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GOAL 3 operates in Healthcare & Life Sciences and is based in the Netherlands. Its latest recorded funding round was a Grant round in March 2026.
GOAL 3 is a medtech company that develops patient monitoring systems and clinical support platforms designed for resource-limited healthcare settings.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GOAL 3 Comparables
Compare GOAL 3 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neopenda | 85% | |
| Sibel Health | 77% | |
| BEMPU Health | 76% |
For institutional investors. Book with your work email.
GOAL 3 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 9, 2026 | ||||
| Grant | Jan 28, 2026 | ||||
| Grant | Sep 22, 2025 | ||||
| Grant | Sep 30, 2024 | ||||
| Seed | May 1, 2022 | ||||
Pre Seed | Feb 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GOAL 3 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIT Solve | Grant |
| HealthTech Hub Africa | Accelerator |
| Philips Foundation Impact Investments B.V. | Seed |
| Johnson & Johnson Foundation | Grant |
| Eurostars SME programme | Grant |
| develoPPP Ventures | Grant |
| European Union | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors grew 357% MoM, reaching 2.3K.
- Mar 9, 2026
$110K grant received from develoPPP Ventures.
For institutional investors. Book with your work email.
GOAL 3 Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GOAL 3's valuation, stock price, and market status.
Is GOAL 3 a public or private company?
GOAL 3 is a private company.
What is the current stock price of GOAL 3?
GOAL 3 is a private company, so its shares have no public market price. Caplight tracks GOAL 3's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GOAL 3 worth (valuation)?
Valuation information for GOAL 3 is not publicly available.
Can I buy GOAL 3 stock?
GOAL 3 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GOAL 3's last funding round?
GOAL 3's most recent funding round was Grant on March 9, 2026.
Who are the main investors in GOAL 3?
Key investors in GOAL 3 include MIT Solve, HealthTech Hub Africa, Philips Foundation Impact Investments B.V., Johnson & Johnson Foundation, Eurostars SME programme.
Will GOAL 3 IPO soon?
No public IPO plans have been announced for GOAL 3.
How can I track GOAL 3 secondary market activity?
Caplight tracks bids, offers, and trades in GOAL 3's shares on secondary markets.